Milestone Scientific Inc (MLSS)

$0.85

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $0.85
    $0.92
    $0.85
    downward going graph

    0.0%

    Downside

    Day's Volatility :7.51%

    Upside

    7.51%

    downward going graph
  • $0.52
    $1.35
    $0.85
    downward going graph

    38.82%

    Downside

    52 Weeks Volatility :61.48%

    Upside

    37.04%

    downward going graph

Returns

PeriodMilestone Scientific IncIndex (Russel 2000)
3 Months
57.41%
0.0%
6 Months
47.14%
0.0%
1 Year
-24.11%
0.0%
3 Years
-49.7%
-19.4%

Highlights

Market Capitalization
65.7M
Book Value
$0.1
Earnings Per Share (EPS)
-0.1
PEG Ratio
0.0
Wall Street Target Price
3.0
Profit Margin
-74.5%
Operating Margin TTM
-65.15%
Return On Assets TTM
-38.25%
Return On Equity TTM
-84.99%
Revenue TTM
9.5M
Revenue Per Share TTM
0.13
Quarterly Revenue Growth YOY
-13.4%
Gross Profit TTM
6.3M
EBITDA
-7.2M
Diluted Eps TTM
-0.1
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.05
EPS Estimate Next Year
-0.05
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Milestone Scientific Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 252.94%

Current $0.85
Target $3.00

Company Financials

FY18Y/Y Change
Revenue
9.6M
↓ 14.71%
Net Income
-7.4M
↑ 43.28%
Net Profit Margin
-77.24%
↓ 31.27%
FY19Y/Y Change
Revenue
8.4M
↓ 12.97%
Net Income
-7.7M
↑ 3.09%
Net Profit Margin
-91.49%
↓ 14.25%
FY20Y/Y Change
Revenue
5.4M
↓ 35.07%
Net Income
-7.5M
↓ 2.28%
Net Profit Margin
-137.69%
↓ 46.2%
FY21Y/Y Change
Revenue
10.3M
↑ 89.52%
Net Income
-7.1M
↓ 4.91%
Net Profit Margin
-69.09%
↑ 68.6%
FY22Y/Y Change
Revenue
8.8M
↓ 14.54%
Net Income
-8.7M
↑ 22.29%
Net Profit Margin
-98.87%
↓ 29.78%
FY23Y/Y Change
Revenue
9.8M
↑ 11.6%
Net Income
-6.9M
↓ 20.41%
Net Profit Margin
-70.51%
↑ 28.36%
Q4 FY22Q/Q Change
Revenue
2.2M
↑ 1.14%
Net Income
-1.9M
↓ 1.22%
Net Profit Margin
-85.68%
↑ 2.05%
Q1 FY23Q/Q Change
Revenue
2.6M
↑ 15.92%
Net Income
-1.3M
↓ 31.9%
Net Profit Margin
-50.34%
↑ 35.34%
Q2 FY23Q/Q Change
Revenue
2.9M
↑ 12.03%
Net Income
-2.2M
↑ 69.49%
Net Profit Margin
-76.16%
↓ 25.82%
Q3 FY23Q/Q Change
Revenue
2.1M
↓ 29.23%
Net Income
-1.5M
↓ 33.84%
Net Profit Margin
-71.2%
↑ 4.96%
Q4 FY23Q/Q Change
Revenue
2.3M
↑ 9.78%
Net Income
-1.9M
↑ 32.23%
Net Profit Margin
-85.77%
↓ 14.57%
Q1 FY24Q/Q Change
Revenue
2.2M
↓ 0.52%
Net Income
-1.4M
↓ 25.7%
Net Profit Margin
-64.06%
↑ 21.71%
FY18Y/Y Change
Total Assets
6.4M
↓ 59.04%
Total Liabilities
4.9M
↓ 40.05%
FY19Y/Y Change
Total Assets
6.6M
↑ 2.43%
Total Liabilities
4.9M
↑ 1.13%
FY20Y/Y Change
Total Assets
19.6M
↑ 198.51%
Total Liabilities
3.5M
↓ 29.69%
FY21Y/Y Change
Total Assets
19.8M
↑ 1.22%
Total Liabilities
3.6M
↑ 3.75%
FY22Y/Y Change
Total Assets
13.7M
↓ 30.83%
Total Liabilities
3.7M
↑ 2.82%
FY23Y/Y Change
Total Assets
11.4M
↓ 17.01%
Total Liabilities
3.4M
↓ 9.11%
Q4 FY22Q/Q Change
Total Assets
13.7M
↓ 10.32%
Total Liabilities
3.7M
↓ 9.81%
Q1 FY23Q/Q Change
Total Assets
12.3M
↓ 10.43%
Total Liabilities
3.0M
↓ 18.24%
Q2 FY23Q/Q Change
Total Assets
11.2M
↓ 9.14%
Total Liabilities
3.4M
↑ 14.18%
Q3 FY23Q/Q Change
Total Assets
10.6M
↓ 5.09%
Total Liabilities
3.6M
↑ 4.08%
Q4 FY23Q/Q Change
Total Assets
11.4M
↑ 7.45%
Total Liabilities
3.4M
↓ 6.45%
Q1 FY24Q/Q Change
Total Assets
11.4M
↓ 0.18%
Total Liabilities
3.9M
↑ 15.82%
FY18Y/Y Change
Operating Cash Flow
-1.6M
↑ 32.43%
Investing Cash Flow
-15.4K
↓ 92.26%
Financing Cash Flow
-250.0K
↓ 153.96%
FY19Y/Y Change
Operating Cash Flow
-1.8M
↑ 9.29%
Investing Cash Flow
-9.9K
↓ 35.7%
Financing Cash Flow
2.6M
↓ 1124.82%
FY20Y/Y Change
Operating Cash Flow
-7.0M
↑ 292.57%
Investing Cash Flow
-21.4K
↑ 116.2%
Financing Cash Flow
19.7M
↑ 669.46%
FY21Y/Y Change
Operating Cash Flow
-4.0M
↓ 42.48%
Investing Cash Flow
-15.2K
↓ 29.15%
Financing Cash Flow
4.6M
↓ 76.8%
Q4 FY22Q/Q Change
Operating Cash Flow
-1.1M
↓ 4.53%
Investing Cash Flow
2.4M
↓ 62707.36%
Financing Cash Flow
-2.1K
↓ 8.61%
Q1 FY23Q/Q Change
Operating Cash Flow
-2.0M
↑ 83.88%
Investing Cash Flow
-4.4M
↓ 280.94%
Financing Cash Flow
-2.2K
↑ 5.05%
Q2 FY23Q/Q Change
Operating Cash Flow
-1.0M
↓ 48.91%
Investing Cash Flow
2.4M
↓ 155.27%
Financing Cash Flow
-2.2K
↑ 0.0%

Technicals Summary

Sell

Neutral

Buy

Milestone Scientific Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Milestone Scientific Inc
Milestone Scientific Inc
26.87%
47.14%
-24.11%
-49.7%
120.72%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
5.19%
21.07%
30.88%
42.93%
154.91%
Resmed Inc.
Resmed Inc.
-4.75%
14.89%
-7.36%
-20.41%
64.31%
Becton, Dickinson And Company
Becton, Dickinson And Company
-3.21%
-2.18%
-12.4%
-6.58%
-8.62%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-3.26%
-8.41%
-16.06%
-14.7%
158.45%
Alcon Ag
Alcon Ag
0.64%
13.85%
6.56%
30.19%
50.52%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Milestone Scientific Inc
Milestone Scientific Inc
NA
NA
0.0
-0.05
-0.85
-0.38
NA
0.1
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
71.38
71.38
7.13
6.29
0.16
0.08
NA
39.37
Resmed Inc.
Resmed Inc.
31.37
31.37
1.75
7.73
0.22
0.12
0.01
31.52
Becton, Dickinson And Company
Becton, Dickinson And Company
49.52
49.52
1.34
13.04
0.05
0.03
0.02
88.74
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
41.68
41.68
6.72
7.76
0.21
0.11
0.0
36.72
Alcon Ag
Alcon Ag
42.7
42.7
4.59
3.07
0.05
0.02
0.0
42.13
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Milestone Scientific Inc
Milestone Scientific Inc
Buy
$65.7M
120.72%
NA
-74.5%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$147.6B
154.91%
71.38
27.16%
Resmed Inc.
Resmed Inc.
Buy
$30.0B
64.31%
31.37
20.91%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$67.0B
-8.62%
49.52
6.76%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$23.2B
158.45%
41.68
19.42%
Alcon Ag
Alcon Ag
Buy
$44.5B
50.52%
42.7
10.96%

Insights on Milestone Scientific Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 2.26M → 2.24M (in $), with an average decrease of 0.5% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -1.93M → -1.44M (in $), with an average increase of 34.6% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 30.9% return, outperforming this stock by 55.0%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 42.9% return, outperforming this stock by 92.6%

Company Information

milestone scientific has developed and currently manufactures, markets and sells “computer-controlled local anesthetic delivery” (c-clad) systems for the improved and painless delivery of local anesthetic. the system is marketed in dentistry under the trademarks compudent & sta system (newest technology). sta™ system is suitable for all dental procedures. compudent™ and the more advanced sta™ system are suitable for all dental injections regularly used in plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, orthopedics and a number of other disciplines. compudent and the sta system is sold in the united states and worldwide in over 25 countries.

Organization
Milestone Scientific Inc
Employees
17
CEO
Mr. Jan Adriaan Haverhals
Industry
Health Technology

FAQs